• Written by: (Investorideas.com newswire, breaking stock market
  • Thu, 12 May 2022
  •   United States

Vancouver, Canada, and Rehovot, Israel - May 12, 2022 (Newsfile Corp.) (Investorideas.com Newswire) Global Wellness Strategies Inc. (CSE: GWS) (OTCQB: GWSFF) (FSE: O3X) announces Shanti Therapeutics MDMA Clinical Trial Update.

Psychedelic Stock News: Global Wellness (CSE: GWS) Readies for First Clinical Trial